We further evaluated the expression of survivin, a key regulator of the cell cycle progression and apoptosis inhibition, that is frequently overexpressed in PDAC and associated with poor prognosis, chemoresistance, tumour proliferation and metastatic potential [43]. The gene discussed is BIRC5; the disease is neoplasm.